Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:BLUE’

Samuel Isaly Orbimed Advisors

Did Hedge Funds Drop The Ball On bluebird bio Inc (BLUE) ?

Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why......(read more)
Samuel Isaly Orbimed Advisors

Is bluebird bio Inc (BLUE) A Good Stock To Buy?

Concerns over rising interest rates and expected further rate increases have hit several stocks hard since the end of the third quarter. NASDAQ and Russell......(read more)
Insider Trading Wall Street Trader Panic

Hedge Fund and Insider Trading News: Brevan Howard Asset Management, EJF Capital, David Einhorn, CoreSite Realty Corp (COR), Caesars Entertainment Co. (CZR), Restoration Robotics Inc (HAIR), and More

Brevan Howard Cuts Office Perks in London Headquarters (Bloomberg) Brevan Howard Asset Management, the hedge fund manager run by billionaire Alan Howard......(read more)
Peter Kolchinsky

Five Stocks To Buy According To Top Biotech-Focused Funds

Biotechnology is a very interesting industry to invest in, but also very complex. If you are looking for stocks that are most likely to see their value......(read more)
Pressmaster/Shutterstock.com

bluebird bio Inc (BLUE), Iqvia Holdings Inc (IQV): Four Biotech Stocks to Buy Now

Healthcare sector has proven itself to be one of the most resilient sectors of the US economy. Since healthcare cannot be outsourced and represents an......(read more)
dna, bio, clone, helix, medical, health, research, cell, gene, microscopic, render, tech, chemistry, molecular, liquid, life, biotechnology, technology, medicine, molecule,

Here’s What’s So Important About The bluebird bio Inc (BLUE) Data

bluebird bio Inc (NASDAQ:BLUE) is up sharply pre market on Thursday, as the company put out fresh interim data from a phase I study of its multiple myeloma......(read more)
dna, bio, clone, helix, medical, health, research, cell, gene, microscopic, render, tech, chemistry, molecular, liquid, life, biotechnology, technology, medicine, molecule,

Is bluebird bio Inc (BLUE) A Good Stock To Buy?

There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating......(read more)
Drew Cupps - Cupps Capital Management

Cupps Capital Slashes Portfolio in Q3, But Couldn’t Stop Buying These 5 Stocks

Drew Cupps‘ Chicago-based asset management firm, Cupps Capital Management, has been in the news of late after it announced that its five-member......(read more)
HedgeFundSentimentChart

Spark Therapeutics Inc (ONCE) and Other Profitable Healthcare Picks of Casdin Capital

At Insider Monkey, we track some 750 hedge funds and other institutional investors. We analyze their 13F filings and determine stocks that they are collectively......(read more)
Jeffrey Ray - Great Point Partners

This Biotech Hedge Fund’s Stock Picks Killed It in Q3

Hedge funds returned about 4% so far this year and underperformed the S&P 500 Index again. Hedge fund investors have been withdrawing their capital......(read more)
JOY CAT ZINC

What is Going On With These 4 Plunging Stocks?

Shares of Freeport-McMoRan Inc (NYSE:FCX), Qiagen NV (NASDAQ:QGEN), McKesson Corporation (NYSE:MCK), and bluebird bio Inc (NASDAQ:BLUE) are deep in the......(read more)
Netflix, Inc. (NASDAQ:NFLX), homepage, streaming, Ipad, video, tv, tablet, app, watch,

Why Are Investors Heading For The Exits In These Five Stocks Today?

In yet another volatile trading session, the S&P 500 is off by more than 0.8% and the NASDAQ is down by 0.84% as investors weigh the negative implications......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Hedge Funds Aren’t Crazy About bluebird bio Inc (BLUE) Anymore

Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors......(read more)
Stan Druckenmiller DUQUESNE CAPITAL

bluebird bio Inc (BLUE), Nektar Therapeutics (NKTR) Among Billionaire Stan Druckenmiller’s Top Small-Cap Picks

Stan Druckenmiller’s Duquesne Family Office LLC, previously Duquesne Capital, has filed its 13F for the reporting period of March 31. Druckenmiller......(read more)
DUQUESNE CAPITAL

Biogen Idec Inc (BIIB), Celgene Corporation (CELG), bluebird bio Inc (BLUE): Stanley Druckenmiller Bets on Biotech and Wins

In the last couple of years, biotechnology industry has been a hot topic and investors have been watching closely as the industry gained on average 40......(read more)
Stan Druckenmiller DUQUESNE CAPITAL

Druckenmiller, Buffett At Odds On International Business Machines Corp. (IBM): What Do Hedge Funds Think? Plus Druckenmiller’s Top New Picks

Duquesne Capital’s Stanley Druckenmiller respects Warren Buffett’s opinion on International Business Machines Corp. (NYSE:IBM); he just doesn’t......(read more)
Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences (GILD), AstraZeneca (AZN), Bellicum Pharmaceuticals (BLCM): Redmile Group’s Top New Picks

Jeremy Green’s Redmile Group entered several new positions last quarter, as revealed by the 13F Form it filed with the U.S. Securities and Exchange......(read more)